HealthQuill Health
Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future climate-related health threats, according to a  statement from the University of Glasgow.
Climate Health Pharma

European body to teach medical students health risks from climate change

Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future.

Read More
Casual use of mental health language often describes behaviours that do not correlate with actual conditions, under the impression that it is “trendy.” 
Health Medical Opinion Pharma

Opinion: Casual mental health words spicing up normal chats not justifiable

By Aparna S October 16, 2024: Is it okay to use mental health words casually in everyday conversations? If you believe that this.

Read More
Drugs Health Medical

Understanding dementia: signs and care strategies for loved ones

Alvina Miller October 15, 2024: Finding out that you or someone close to you might have dementia can be really upsetting. But learning.

Read More
Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.
Drugs Health Medical

Breakthrough treatment may end insulin use in type 2 diabetic patients

HQ Team October 15, 2024: A recent study presented at the United European Gastroenterology Week congress in Vienna unveiled a procedure that could.

Read More
Uric acid may emerge as a potential therapy to treat ischemic stroke after US researchers discovered a new method in studies on animals.
Drugs Health Medical

Danish study reveals half of patients with sepsis die within two years

HQ Team October 15, 2024: Severe sepsis and septic shock are major causes of mortality in intensive care unit (ICU) patients. According to.

Read More
British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a standard-of-care combination, according to the company.
Drugs Health Medical

New CAR T-cell therapy offers hope for children with aggressive blood cancer

HQ Team October 14, 2024: Children with aggressive blood cancer may soon have access to a new treatment, CAR T-cell therapy, targeting T-cell.

Read More
H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug to treat seizures in a group of rare epilepsies.
Drugs Health Pharma

Lundbeck targets epileptic drug, to buy Longboard for $2.6 billion

H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug.

Read More
Seventeen dangerous disease outbreaks, such as the Marburg virus and the latest strain of avian influenza this year, have increased the likelihood of new pandemics, and global readiness remains inadequate, according to the World Health Organization.
Drugs Health Pharma

Pandemic threat looms, nations unprepared to handle crisis: WHO

Seventeen dangerous disease outbreaks, such as the Marburg virus and the latest strain of avian influenza this year, have increased the likelihood of.

Read More
Microbiologists at Northwestern University have found toothbrushes and showerheads were teeming with diverse viruses not seen so far — and they don’t target humans, but bacteria.
Drugs Health Pharma

`Toothbrushes, showerheads nurture human-friendly bacteria’

Microbiologists at Northwestern University have found toothbrushes and showerheads were teeming with diverse viruses not seen so far — and they don’t target.

Read More
Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder in haemophilia patients.
Drugs Health Pharma

Pfizer’s drug to treat rare haemophilia disorder gets US regulator’s approval

Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder.

Read More